Predicting Toxicity in Elderly Patients With Head and Neck Cancer
ConditionHead and Neck Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age70-99
SponsorEuropean Institute of Oncology
About this trial
Predicting toxicity in elderly patients with head and neck cancer:
validating a disease-oriented toxicity predictive tool and integrating it with avail-able screening tools for better outcomes.
Eligibility criteria
Qualifiers
Patients aged ≥ 70 years
Histological diagnosis of squamous cell or undifferentiated HNC in stage III-IV AJCC ed VIII (si-nonasal, nasopharynx, oral cavity, oropharynx, unknown primary with HPV pos, larynx and hy-popharynx) and candidated to curative non surgical treatment (radiotherapy alone, Chemora-diation with platinum salts; radiation+cetuximab)
Evaluable disease accordingly to RECIST criteria 1.1
Willing of sign a written informed consent
Disqualifiers
PS ECOG 3-4
Patients who received systemic treatments in the past for other primary tumors
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov